Oxford Nanopore Technologies PLC (ONT.L) stock: key figures, P/E, revenue and dividend

Health Care · United Kingdom · ISIN GB00BP6S8Z30

Price
2.10 GBP
Market cap
2.02 bn GBP
P/E (2025)
–
P/S (2025)
9.03
Dividend yield
0.00 %
Net margin
-64.85 %
Return on equity (ROE)
-31.34 %
Return on assets (ROA)
-23.33 %

Oxford Nanopore Technologies PLC financials

Fiscal year20242025
Revenue183.00 m GBP223.90 m GBP
Gross profit105.00 m GBP131.30 m GBP
Operating income-152.30 m GBP-155.30 m GBP
EBIT-152.00 m GBP–
Net income-146.00 m GBP-145.20 m GBP
Diluted EPS – continuing operations-0.16 GBP–

Full history since 2012, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Oxford Nanopore Technologies PLC

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version of hardware, software, and chemistry. It also provides PromethION products, such as PromethION 2, PromethION 24, and PromethION 48. The company has a collaboration with Cepheid to develop and commercialize automated infectious disease sequencing solutions. It operates in the region of Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.